GEMMA Biotherapeutics Secures $34 Million Seed Funding GEMMA Biotherapeutics is a new therapeutics company established by Dr. Jim Wilson, a gene therapy specialist, and has closed its seed funding at $34 million. This investment will support the company’s clinical-stage gene therapy programs and growth of operations. Visit: https://nextdigitalhealth.com/funding-news/gemma-biotherapeutics-secures-34-million-seed-funding/ #GEMMABiotherapeutics #GeneTherapy #JimWilson #BiotechInnovation #Biotherapeutics #GeneTherapyResearch